(Q51606467)

8 April 2018

title

Is taking part in clinical trials good for your health? A cohort study. (English)

1 reference

8 April 2018

author

Kevin M. Goode

3

1 reference

8 April 2018

John Cleland

4

1 reference

8 April 2018

author name string

Andrew L Clark

1

1 reference

8 April 2018

Michael J Lammiman

2

1 reference

8 April 2018

publication date

1 November 2009

1 reference

8 April 2018

European Journal of Heart Failure

published in

1 reference

8 April 2018

volume

11

1 reference

8 April 2018

issue

11

1 reference

8 April 2018

page(s)

1078-1083

1 reference

8 April 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP133

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP133

Survival of patients with a new diagnosis of heart failure: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP133

External validity of randomised controlled trials: "to whom do the results of this trial apply?".

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP133

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP133

Incidence and aetiology of heart failure; a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP133

Are hematinic deficiencies the cause of anemia in chronic heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP133

Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP133

A meta-analysis of the association between adherence to drug therapy and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP133

Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP133

Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect".

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP133

Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP133

Systematic review to determine whether participation in a trial influences outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP133

More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP133

External Validity of Clinical Trials in Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP133

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFP133

1 reference

8 April 2018

1 reference

8 April 2018